NCT00887159
Clinical Trial Information
Trial Number: NCT00887159 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Small Cell Lung Cancer
Trial Title:
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Small Cell Lung Cancer
Study ID:
E1508
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00887159-D2 | There are two different submissions (each with one dataset) for PMID 27163943 from trial ECOG-ACRIN 1508. This dataset, NCT00887159-D2 contains toxicity data. Dataset NCT00887159-D1 contains baseline, treatment, and efficacy data. |
| NCT00887159-D1 | There are two different submissions (each with one dataset) for PMID 27163943 from trial ECOG-ACRIN 1508. This dataset, NCT00887159-D1, contains baseline, treatment, and efficacy data. Dataset NCT00887159-D2 contains toxicity data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®